11 patents
Utility
Regulatory T cell epitopes, compositions and uses thereof
29 Jun 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 22 Jun 18
Utility
Regulatory T cell epitopes, compositions and uses thereof
29 Jun 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 22 Jun 18
Utility
Regulatory T cell epitopes, compositions and uses thereof
29 Jun 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 22 Jun 18
Utility
Regulatory T cell epitopes, compositions and uses thereof
29 Jun 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 22 Jun 18
Utility
Regulatory T cell epitopes, compositions and uses thereof
29 Jun 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 16 Oct 18
Utility
Regulatory T cell epitopes, compositions and uses thereof
23 Feb 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 22 Jun 18
Utility
Regulatory T cell epitopes, compositions and uses thereof
23 Feb 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 22 Jun 18
Utility
Regulatory T cell epitopes, compositions and uses thereof
23 Feb 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 16 Oct 18
Utility
Regulatory T cell epitopes, compositions and uses thereof
23 Feb 21
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 4 Mar 19
Utility
Peptides for inducing Chagas disease responses
2 Nov 20
The present disclosure relates to vaccine formulations and their use in treating and preventing Chagas Disease.
Daniel Hoft, Chris Eickhoff, Annie De Groot
Filed: 5 Jun 16
Utility
Regulatory T cell epitopes, compositions and uses thereof
24 Aug 20
The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region.
Anne De Groot, William Martin, Daniel S. Rivera
Filed: 21 Jun 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first